Search for: "Gottlieb v Gottlieb" Results 341 - 360 of 397
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Mar 2008, 4:10 am
Delaware: Advanced Notice Bylaw Limited to Rule 14a-8 Proposals From Travis Laster: A few weeks ago - in Jana Master Fund Ltd. v. [read post]
1 Feb 2019, 6:05 am
Barry, Cleary Gottlieb Steen & Hamilton LLP, on Sunday, January 27, 2019 Tags: Equity-based compensation, Executive Compensation, Incentives, Institutional Investors, institutional Shareholder Services Inc. [read post]
15 Nov 2019, 6:17 am
Preston and Michael James, Cleary Gottlieb Steen & Hamilton LLP, on Sunday, November 10, 2019 Tags: Asset management, Capital markets, ESG, Impact investing, International governance, Shareholder activism Understanding the Impact of America’s Clampdown on Proxy Advisors Posted by Amy Freedman, Michael Fein, and Ian Robertson, Kingsdale Advisors, on Sunday, November 10, 2019 Tags: Boards of Directors, Institutional… [read post]
12 Jun 2019, 11:56 am by Jeff Margulies (US)
In a statement, FDA Commission Scott Gottlieb, M.D., stated: We’ve taken this position because we too have carefully reviewed the most current research on coffee and cancer and it does not support a cancer warning for coffee. [read post]
24 Aug 2018, 6:06 am
Maldonado, Cleary Gottlieb Steen & Hamilton LLP, on Tuesday, August 21, 2018 Tags: Board composition, Board turnover, Boards of Directors, Disclosure, Diversity, Engagement, Institutional Investors, Shareholder voting Corporate Governance in Emerging Markets Posted by Ruth V. [read post]
5 Apr 2019, 5:58 am
Pruitt, Jones Day, on Tuesday, April 2, 2019 Tags: Broker-dealers, Conflicts of interest, Disclosure, Investment advisers, Investor protection, Mutual funds, Reporting regulation, Retail investors, SEC, SEC enforcement FCPA and the Commodity Exchange Act: A New Relationship Posted by David Yeres, David DiBari, and Robert Houck, Clifford Chance US LLP, on Tuesday, April 2, 2019 Tags: Anti-corruption, CFTC, Commodity… [read post]
24 Sep 2018, 8:19 pm by Georgina Hey (AU)
As a result, producers of plant-based dairy alternative beverages have been freely using the term “milk” to describe their products for decades, despite the fact that, as FDA Commissioner Scott Gottlieb quipped at a summit in July, “an almond doesn’t lactate”. [read post]
27 Apr 2018, 6:01 am
Posted by Vishal Gupta, Sandra Mortal, and Xiaohu Guo (University of Alabama), on Saturday, April 21, 2018 Tags: Compensation ratios, Diversity, Executive Compensation, Management Corporate Governance Deviance Posted by Ruth V. [read post]
12 Apr 2019, 6:20 am
Securities and Exchange Commission, on Wednesday, April 10, 2019 Tags: Accountability, No-action letters, Public interest, SEC, Securities regulation, Transparency Executive Long-Term Incentive Plans Posted by Joseph Kieffer, Equilar Inc., on Thursday, April 11, 2019 Tags: Compensation ratios, Equity-based compensation, Executive Compensation, Incentives, Management, Pay for performance The SEC v. [read post]
12 Jun 2019, 11:56 am by Jeff Margulies (US)
In a statement, FDA Commission Scott Gottlieb, M.D., stated: We’ve taken this position because we too have carefully reviewed the most current research on coffee and cancer and it does not support a cancer warning for coffee. [read post]
5 Aug 2016, 6:27 am
Loseman, Gibson, Dunn & Crutcher LLP, on Saturday, July 30, 2016 Tags: Class actions, Delaware cases, Delaware law, Disclosure, Fraud-on-the-Market, Halliburton, Merger litigation,Omnicare v. [read post]
16 Apr 2021, 5:51 am
Llewellyn, Fenwick & West LLP, on Sunday, April 11, 2021 Tags: Board composition, Boards of Directors, California, Diversity, ESG, Human capital, Management, Tech companies Supreme Court to Weigh in on Presumption of Reliance in Securities Class Actions: Goldman Sachs v. [read post]
7 Jun 2018, 9:30 pm by Bobby Chen
FDA Commissioner Scott Gottlieb stated that the “warning letters go right to the source of this illegal activity to let online network operators know that marketing illegal and unapproved opioids directly to U.S. consumers will not go unchallenged by the FDA. [read post]
2 Nov 2015, 3:09 am by Peter Mahler
Add to the growing list of equity-driven rulings for these contract-centric creatures of statute an unpublished decision last week by a New Jersey intermediate appellate court in All Saints University of Medicine Aruba v Chilana, No. [read post]